BIIB: initiated starter positions on Biogen as it trades near 10 year low. Stock momentum is poor so ot might continue to fall over the various headwinds on the general Pharma sector and specifically on its product pipeline as well.
Pharma companies are notoriously volatile so dabble with eyes open.
精彩评论